Form 8-K - Current report:
SEC Accession No. 0001213900-24-110769
Filing Date
2024-12-20
Accepted
2024-12-20 08:00:10
Documents
14
Period of Report
2024-12-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0225308-8k_acuren.htm   iXBRL 8-K 24498
2 PRESS RELEASE ISSUED BY ACUREN CORPORATION ON DECEMBER 20, 2024 ea022530801ex99-1_acuren.htm EX-99.1 173417
  Complete submission text file 0001213900-24-110769.txt   385848

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cik0002032966-20241220.xsd EX-101.SCH 3072
4 XBRL LABEL FILE cik0002032966-20241220_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cik0002032966-20241220_pre.xml EX-101.PRE 22388
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0225308-8k_acuren_htm.xml XML 3476
Mailing Address 14434 MEDICAL COMPLEX DRIVE #100 TOMBALL TX 77377
Business Address 14434 MEDICAL COMPLEX DRIVE #100 TOMBALL TX 77377 800-218-7450
ACUREN CORP (Filer) CIK: 0002032966 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-282976 | Film No.: 241565156
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)